Search
Displaying 161–170 of 779 for “retinitis clinical trial”
-
Recording Available: Insights Forum | Wednesday, June 24, 2026
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on June 24, 2026.
-
Foundation Awarded 21 New Grants in FY2021 Totaling More than $14.2 Million
Research NewsCurrent research portfolio is comprised of nearly 100 projects at prominent institutions around the world
-
VISIONS 2024, the national conference of the Foundation Fighting Blindness, is a one-of-a-kind event in which individuals who are visually impaired, and their families, have the opportunity to hear about exciting advancements in blindness research.
-
Need-to-Know Information about Clinical Trials
Research NewsA primer on what you can expect from clinical trials.
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Fiscal Year 2026 (July 1, 2025 – June 30, 2026)
-
Information for affected individuals and their families about the role of genetic counseling.
-
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Research NewsReports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
Adverum Advancing Wet AMD Gene Therapy into Phase 3 Clinical Trials
Research NewsIn earlier clinical trials, the emerging gene therapy greatly reduced the treatment burden associated with injections of approved anti-VEGF therapies.
-
Over Thirty Presentations Highlighted during the 2022 Retinal Cell & Gene Therapy Innovation Summit
Research NewsIn its seventh year, the Retinal Cell & Gene Therapy Innovation Summit featured 34 presentations from industry experts from around the world.
.png)
